Neurocrine Biosciences
NBIX
#1239
Rank
S$19.58 B
Marketcap
$193.43
Share price
1.39%
Change (1 day)
9.51%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

EPS for Neurocrine Biosciences (NBIX)

EPS in 2023 (TTM): $2.67

According to Neurocrine Biosciences 's latest financial reports the company's current EPS (TTM) is $2.68. In 2022 the company made an earnings per share (EPS) of $2.20 an increase over its 2021 EPS that were of $1.30.

EPS history for Neurocrine Biosciences from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.6721.48%
2022$2.2069.47%
2021$1.30-78.21%
2020$5.96990%
2019$0.5581.82%
2018$0.30-113.5%
2017-$2.230.62%
2016-$2.2257.28%
2015-$1.4125.61%
2014-$1.1218.84%
2013-$0.94-1085.71%
2012$0.09572-89.71%
2011$0.93-500%
2010-$0.23-86.92%
2009-$1.78-43.48%
2008-$3.15-57.8%
2007-$7.4592.58%
2006-$3.87371.67%
2005-$0.82-52.76%
2004-$1.7436.56%
2003-$1.27-70%
2002-$4.24118.31%
2001-$1.948.4%
2000-$1.7948.86%
1999-$1.20-20%
1998-$1.50-479.31%
1997$0.40

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$2.86 6.63%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.75-71.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
-$4.05-251.02%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.42 177.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.03 87.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.54-5.10%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.64-123.98%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.14-254.59%๐Ÿ‡บ๐Ÿ‡ธ USA